Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

VTRS

Viatris (VTRS)

Viatris Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTRS
DateTimeSourceHeadlineSymbolCompany
03/04/20216:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VTRSViatris Inc
03/04/20216:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VTRSViatris Inc
03/04/20216:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VTRSViatris Inc
03/04/20216:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VTRSViatris Inc
03/04/20216:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VTRSViatris Inc
03/04/202111:37AMPR Newswire (US)Viatris Inc. to Participate in Barclays Global Healthcare ConferenceNASDAQ:VTRSViatris Inc
03/01/20216:58AMPR Newswire (US)Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platfo...NASDAQ:VTRSViatris Inc
02/25/20215:03PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:VTRSViatris Inc
02/24/20216:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VTRSViatris Inc
02/22/20217:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VTRSViatris Inc
02/22/20216:59AMPR Newswire (US)Viatris Inc. Announces 2021 Financial Guidance and Reaffirms Strategic and Financial CommitmentsNASDAQ:VTRSViatris Inc
02/18/20217:30AMPR Newswire (Canada)Viatris Launches Hulio® (adalimumab biosimilar) in CanadaNASDAQ:VTRSViatris Inc
02/18/20217:30AMPR Newswire (Canada)Viatris lance HulioMD (biosimilaire de l'adalimumab) au CanadaNASDAQ:VTRSViatris Inc
02/12/20216:49PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:VTRSViatris Inc
02/09/20213:17PMPR Newswire (US)Viatris Inc. to Hold Conference Call on Monday, Feb. 22, 2021, to Discuss 2021 Financial GuidanceNASDAQ:VTRSViatris Inc
02/04/202110:28AMEdgar (US Regulatory)Schedule 13gNASDAQ:VTRSViatris Inc
02/02/20213:18PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VTRSViatris Inc
01/29/20214:47PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:VTRSViatris Inc
01/08/20212:52PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VTRSViatris Inc
01/03/20213:25AMTipRanksWeekly Market Review: Ending on a High NoteNASDAQ:VTRSViatris Inc
12/18/20206:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VTRSViatris Inc
12/18/202012:21PMPR Newswire (US)Mylan Wins Summary Judgment in EpiPen® Litigation Brought by SanofiNASDAQ:VTRSViatris Inc
12/15/20206:44PMPR Newswire (US)Viatris Inc. Recommends Caution on TRC Capital Corp.'s Attempt to Acquire Shares at a Significant Discount via Mini-Tender Of...NASDAQ:VTRSViatris Inc
12/11/20208:30AMPR Newswire (US)Viatris Inc. Announces Additional Details of Previously Disclosed Global Restructuring InitiativeNASDAQ:VTRSViatris Inc
12/11/20207:30AMDow Jones NewsPfizer Raises Quarterly Dividend by a Penny a ShareNASDAQ:VTRSViatris Inc
12/10/20208:00AMPR Newswire (US)Viatris Inc. to Present at the J.P. Morgan 39th Annual Healthcare Conference January 14, 2021 and Will Host its Inaugural Inv...NASDAQ:VTRSViatris Inc
12/07/20208:00AMPR Newswire (US)Sesame Workshop and Viatris Inc. Launch Global Resources to Help Children and Caregivers Manage Social and Emotional Needs Du...NASDAQ:VTRSViatris Inc
11/23/20203:34PMPR Newswire (US)Viatris Inc. Announces FDA Tentative Approval of a Pediatric Formulation of Dolutegravir (DTG) Under PEPFARNASDAQ:VTRSViatris Inc
 Showing the most relevant articles for your search:NASDAQ:VTRS